vision loss tirzepatide macular degeneration NEJM Editorial Fellow Katerina Lin, MD, unpacks the science behind a study on tirzepatide and vision loss TGA

The tapering timeline should always be individualized

It's important to note that tirzepatide is not recommended for patients with severe gastrointestinal disease, including severe gastroparesis, as its effects on gastric emptying may worsen these conditions

If you notice persistent or concerning menstrual changes while taking tirzepatide, speaking with a qualified healthcare provider can help you better understand whats happening and determine the best next steps for your health

Can you contact the listed laboratory

Hair loss is something many patients on tirzepatide notice, and it is a legitimate topic worth understanding

Furthermore, it supports investigations into non-alcoholic steatohepatitis mechanisms actively